| Name | Title | Contact Details |
|---|---|---|
Peter Ullrich |
Founder and Chief Executive Officer | Profile |
Amicable Healthcare Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Katadyn North America is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sicel Technologies Inc is a Morrisville, NC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We are passionate about our work and compassionate toward our people, whether they work here or seek care from us. We opened the first AbsoluteCare center in Atlanta in 2000, with a primary focus on treating members with HIV/AIDS. We quickly became an HIV Center of Excellence, achieving impressive results: an 88 percent retention rate and a 97 percent undetectable rate. A surprising thing happened. With so many of them free of the symptoms of HIV/AIDS, our members sought primary care from us. They were coming in for help controlling asthma, diabetes, heart disease, hypertension, and all the other conditions that life and aging had thrown their way. So we transformed. We assembled a larger team of qualified, passionate practitioners to offer whole-life care in a new, larger center. And in the last two decades, we have expanded our facilities to multiple locations in several states, where we offer our members everything from primary care to nutrition counseling, behavioral health, and life services. The members who set foot in an AbsoluteCare center are usually underserved. With their health already compromised, life`s daily stressors add to their level of need.
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.